Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01649791. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT07254754. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01118845. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01718691. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy
ClinicalTrials.gov study NCT02544724. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas
ClinicalTrials.gov study NCT04933617. IPD Sharing: YES. Countries: 1. Publications: 0.
Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy
ClinicalTrials.gov study NCT01679119. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma
ClinicalTrials.gov study NCT00058422. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01369784. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)
ClinicalTrials.gov study NCT03298412. IPD Sharing: YES. Countries: 7. Publications: 0.
Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder
ClinicalTrials.gov study NCT04337827. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05800366. IPD Sharing: YES. Countries: 1. Publications: 0.
Role of Regulatory B Cells in Behçet's Disease
ClinicalTrials.gov study NCT04376411. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02920697. IPD Sharing: YES. Countries: 8. Publications: 0.
Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma
ClinicalTrials.gov study NCT02855359. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00474188. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT02611323. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06392477. IPD Sharing: YES. Countries: 5. Publications: 0.
S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01359592. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
ClinicalTrials.gov study NCT06736613. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.